ArticleThe Lancet. Oncology2017

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma - Authors' reply.

Elizabeth C Smyth et al.PubMed ↗Publisher ↗

No numbers read from the abstract.